Publication 3/20/2000

Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.

Stedman H, Wilson JM, Finke R, Kleckner AL, Mendell J

Human Gene Therapy